about
Restorative cell therapy for Parkinson's disease: a quest for the perfect cell.Critical issues of clinical human embryonic stem cell therapy for brain repair.Emerging restorative treatments for Parkinson's disease.Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.Impaired APP activity and altered Tau splicing in embryonic stem cell-derived astrocytes obtained from an APPsw transgenic minipig.Porcine embryonic stem cells: a possible source for cell replacement therapy.From zygote to implantation: morphological and molecular dynamics during embryo development in the pig.Early embryonic development, assisted reproductive technologies, and pluripotent stem cell biology in domestic mammals.Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead.Evaluation of porcine stem cell competence for somatic cell nuclear transfer and production of cloned animals.Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells.Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.Identification of SSEA-1 expressing enhanced reprogramming (SEER) cells in porcine embryonic fibroblasts.Production of a cloned calf using zona-free serial nuclear transfer.Effect of exogenous DMNPE-caged ATP on in vitro-matured bovine oocytes prior to parthenogenetic activation, fertilisation and nuclear transfer.Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells.Derivation and characterization of sleeping beauty transposon-mediated porcine induced pluripotent stem cells.Nuclear lamin antigen and messenger RNA expression in bovine in vitro produced and nuclear transfer embryos.Dynamic changes in epigenetic marks and gene expression during porcine epiblast specification.Temporal repression of endogenous pluripotency genes during reprogramming of porcine induced pluripotent stem cells.Porcine pluripotency cell signaling develops from the inner cell mass to the epiblast during early development.Expression profiling of genes crucial for placental and preimplantation development in bovine in vivo, in vitro, and nuclear transfer blastocysts.Analysis of gene transcription in bovine nuclear transfer embryos reconstructed with granulosa cell nuclei.Breaking down pluripotency in the porcine embryo reveals both a premature and reticent stem cell state in the inner cell mass and unique expression profiles of the naive and primed stem cell states.Isolation and culture of porcine primary fetal progenitors and neurons from the developing dorsal telencephalonEmbryonic stem cells and Parkinson's disease: cell transplantation to cell therapyUltrastructural and molecular distinctions between the porcine inner cell mass and epiblast reveal unique pluripotent cell statesMammalian embryo comparison identifies novel pluripotency genes associated with the naïve or primed stateEvidence for nucleolar dysfunction in Alzheimer's diseaseDenmark's exemplary gender balance trips up in scienceGeneration of transgene-free porcine intermediate type induced pluripotent stem cells
P50
Q33303971-46663383-02AB-4010-8250-B0165570705CQ33318601-3DD3BCB6-EFFA-47AB-A0DE-8CC8D45B0F94Q33347369-7CB40B96-F479-47FE-A733-4A0FE6B64194Q33772627-8AE2AF9E-E138-40E0-9359-5AD4DCA8390FQ36175360-B033DB21-8502-4C68-AF9C-B78E8F39F789Q37260412-4767700C-6E73-4A9A-A232-7F69DB7BF676Q37574174-6CCF53ED-18D8-439A-94E1-146EC8F5653CQ38117919-6DF4989E-4F8D-46D0-B783-7EF02E838DC9Q38559734-84E082A5-E8F7-4341-A10B-2E90090980A2Q38719311-C6BCD63F-1ACA-470A-AE56-E7B336EF48F4Q38731990-79422A9C-E89B-4952-9AA3-5A4243CF3A44Q38762099-3FE431C8-B9B8-4C09-AE15-9FCB91C1907FQ38828827-558F2DB5-FECC-4FEC-86CB-DC71AAAA4AA6Q40404870-143D2FA1-3B7B-4C07-99A6-F2BEF00791A5Q45290115-368D300F-6EE7-4241-BD64-143A28E0A7EDQ47412734-AF15297D-2A94-490A-B185-F57C7822CD5FQ50490525-E9FC4397-BA23-4EE2-972A-40F9CFB0369BQ50657576-F817269B-32B6-4B23-A141-2A37C8CF6D45Q51443747-25E1B09E-90FD-4C0A-8D93-88B30316C2BCQ51784334-501BDEF8-91F0-4E4C-84E0-A9C93D20FFC6Q51930074-3B1F3547-79C9-4631-87A7-C1D18BC431E3Q52049679-5C8535CF-23A0-45CD-9BF8-BD681679DF90Q52165188-4CEF588F-AF14-43A1-9B3A-6D7740C632D2Q54359332-88C55249-EF3A-494C-BDC1-DF451D97B379Q64101866-C61E2A6D-206C-4B8B-BA42-280C33377351Q81027326-07920DF3-7584-4585-896E-9336D2B69EF8Q85076076-A88DF833-D1D8-4EFC-98D5-04D952A50A9FQ90349025-7AD71E30-1617-4614-97FE-982AC80574A1Q92227610-938F82DA-64E0-4922-B911-D8E658FFD719Q92461284-064071EF-DCBF-4C6B-B56E-EC76A35980E1Q93236928-EEFFCFAB-0123-4B11-BBDD-21386E2EA4E4
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vanessa J Hall
@nl
Vanessa J Hall
@sl
Vanessa J. Hall
@en
Vanessa J. Hall
@es
type
label
Vanessa J Hall
@nl
Vanessa J Hall
@sl
Vanessa J. Hall
@en
Vanessa J. Hall
@es
altLabel
Vanessa G. Hall
@en
prefLabel
Vanessa J Hall
@nl
Vanessa J Hall
@sl
Vanessa J. Hall
@en
Vanessa J. Hall
@es
P106
P1153
14631988800
P21
P31
P4012
P496
0000-0002-3598-2214